Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
R&D channel feed
Updated: Viridian reveals first Phase 3 eye disease data in bid to compete with Tepezza
8 months ago
Pharma
Centessa to take narcolepsy drug into Phase 2 after no sign of side effects that doomed earlier competitor
8 months ago
Bayer's treatment for menopause symptoms hits primary endpoints in third late-stage trial
8 months ago
Pharma
#WCLC24 roundup: ArriVent thinks its drug can fill Tagrisso's gaps; Boehringer, Bayer's data in HER2-mutated lung cancer
8 months ago
GSK says long-acting asthma hopeful significantly cut attacks
8 months ago
Pharma
AstraZeneca, Gilead detail TROP2 ADC data in lung cancer as they search for new ways forward
8 months ago
Zealand’s GLP-1/GLP-2 drug bounces back with new Phase 1b data
8 months ago
#ESMO24 roundup: New data on Amgen’s PRMT5 inhibitor seem lackluster, and Jazz’s HER2 antibody
8 months ago
AstraZeneca's monoclonal antibody misses primary endpoint in mid-stage trial in COPD
8 months ago
Bicycle Therapeutics makes an early case for its Padcev competitor: #ESMO24
8 months ago
Merck, Daiichi Sankyo detail Phase 2 ADC results in small cell lung cancer, bispecific combo strategy
8 months ago
Relay Therapeutics reports positive PFS data for its PI3Kα inhibitor combo in breast cancer
8 months ago
Terns’ oral GLP-1 passes Phase 1 test with promising weight loss after one month
8 months ago
Summit's Phase 3 data back up biotech's boasts of beating Keytruda in lung cancer
8 months ago
China
Exclusive: Influential Democrat will oppose Biosecure Act ahead of House vote
8 months ago
Deals
China
BridgeBio sticks to script for ATTR-CM as Alnylam cleans up ‘typo’ snafu
8 months ago
Pharma
Milestone’s arrhythmia drug on track for China filing with new Phase 3 data
8 months ago
FDA+
GSK’s Nucala cuts exacerbations in Phase 3 COPD trial, but numbers remain under wraps
8 months ago
Lilly unveils more positive late-stage data for its once-weekly insulin
8 months ago
IN8bio pauses glioblastoma program, halves workforce as it prioritizes leukemia asset
8 months ago
People
Higher dose of Spinraza helped spinal muscular atrophy patients, Biogen says
8 months ago
Pharma
Moderna’s mpox vaccine outperforms approved version in preclinical study
8 months ago
Pharma
Transplant biotech eGenesis snags $191M after first use of gene-edited pig kidney
8 months ago
Financing
Roche unveils more mid-stage data for BTK inhibitor in relapsing multiple sclerosis
8 months ago
Pharma
First page
Previous page
28
29
30
31
32
33
34
Next page
Last page
Confirm Profile
Full Name
Email
Company
Job Title
{@!--CONSENT--!@}
Submit